A class of diabetes medications already celebrated for heart and kidney protection may be quietly reshaping outcomes in spinal surgery — a finding that challenges the assumption that glycemic control is the only perioperative variable that matters for diabetic surgical patients. For the millions of adults with type 2 diabetes who undergo cervical spine procedures each year, this adds meaningful nuance to preoperative medication management decisions.
Using the large-scale TriNetX database, investigators performed a 1:1 propensity-matched comparison of 1,585 ACDF (anterior cervical discectomy and fusion) patients who were using SGLT2 inhibitors perioperatively against an equal number of matched controls. The SGLT2i group showed a 41% relative reduction in postoperative emergency department visits. More strikingly, at one year, pseudoarthrosis — a failure of the vertebral bones to fuse properly — occurred in 4.9% of SGLT2i users versus 6.8% of controls (RR 0.73), a difference that reached statistical significance. Five-year reoperation rates were also lower in the SGLT2i cohort, suggesting durability of the protective effect beyond the immediate postoperative window.
These findings are scientifically plausible given SGLT2 inhibitors' known anti-inflammatory, anti-fibrotic, and metabolic effects that extend well beyond blood sugar lowering. Reduced systemic inflammation could improve the bone remodeling and vascular environment required for successful fusion. That said, several important caveats apply. This is a retrospective observational study, meaning causality cannot be established — patients prescribed SGLT2 inhibitors may differ systematically from those on other diabetes regimens in ways propensity matching cannot fully resolve. Notably, SGLT2 inhibitors carry a known risk of euglycemic diabetic ketoacidosis when used perioperatively, which current guidelines recommend mitigating by pausing use before surgery. The apparent benefits observed here must therefore be weighed carefully against that risk in clinical context. This study is best characterized as hypothesis-generating; a prospective trial with controlled perioperative protocols would be needed before practice patterns shift.